Rani Therapeutics Holdings Inc. (RANI)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 64
-0.04
-5.7941%
$
52.19M Market Cap
- P/E Ratio
- Div Yield
589,110 Volume
-0.82 Eps
$ 0.68
Previous Close Want to track RANI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Rani Therapeutics Holdings Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Farallon Capital Farallon Capital Management LLC | 20,700 | $27,945 | $14,092.56 | -$13,852.44 | -49.57% |
| SAS Stephane Astruc/ Salomon Sebban J. Safra Sarasin Holding AG | 17,000 | $12,931 | $10,883.4 | -$2,047.6 | -15.83% |
 Li Peng China Universal Asset Management Co. Ltd. | 17,887 | $22,939.04 | $11,631.92 | -$11,307.12 | -49.29% |
 Christopher C. Powers Farther Finance Advisors, LLC | 13,800 | $18,630 | $9,246 | -$9,384 | -50.37% |
 Raymond Debbane Siren, L.L.C. | 2M | $2.7M | $1.36M | -$1.34M | -49.63% |
 Scott Schroeder Longaeva Partners LP | 2.33M | $3.01M | $1.53M | -$1.48M | -49.29% |
| TS Todd Stoner Disciplined Investors LLC | 12,200 | $16,470 | $8,199.62 | -$8,270.38 | -50.21% |
2026 © Marketlog. All Rights Reserved.
